Pharmacology

Action Mechanism of Action Reference
RNAI INHIBITOR Complement C5 mRNA RNAi inhibitor ClinicalTrials Other PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Glomerulonephritis, IGA 2 D005922 ClinicalTrials
Atypical Hemolytic Uremic Syndrome 2 D065766 ClinicalTrials
Hemoglobinuria, Paroxysmal 2 D006457 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297722
FDA SRS S66Z65E10T